Hodgkin Lymphoma, Version 1.2026

Hodgkin Lymphoma, Version 1.2026 JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK Advani, R. H., Kelsey, C. R., Armand, P., Bello, C. M., Benitez, C. M., Bond, D., Chen, W., Cherian, S., Czader, M., Dabaja, B., Daly, M. E., Frosch, Z., Gordon, L. I., Hansen, N., Herrera, A. F., Hochberg, E. P., Hoppe, R. T., Isufi, I., Johnston, P. B., Kelly, K., Kenkre, V. P., Kline, J., Lynch, R. C., McConathy, J., Morgan, D., Niu, A., Paul, S., Rabinovitch, R., Salavati, A., Sano, D., Shah, H., Spinner, M., Svoboda, J., Winter, J. N., Yahalom, J., Yang, J. C., Montgomery, S., Stehman, K. 2026; 24 (2): 41-60

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hodgkin lymphoma provide expert, multidisciplinary recommendations for the diagnosis and treatment of Hodgkin lymphoma. The panel convenes annually to update recommendations based on a review of recently published clinical trials. This selection from the NCCN Guidelines for Hodgkin Lymphoma focuses on the management of newly diagnosed and relapsed/refractory classic Hodgkin lymphoma in adults aged 18 to 60 years.

View details for DOI 10.6004/jnccn.2026.0006

View details for Web of Science ID 001705739400012

View details for PubMedID 41671432